Nurix Therapeutics (NRIX) EBITDA (2019 - 2026)
Nurix Therapeutics' EBITDA came in at -$91.95 million for fiscal Q2 2026 (quarter ended May 31, 2026), compared with -$46.08 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to May 31, 2026, Nurix Therapeutics reported EBITDA of -$352.58 million; for FY2025 (ended Nov 30, 2025), it was -$276.93 million.
- Going back by fiscal year, EBITDA was -$203.71 million in FY2024, -$147.53 million in FY2023, -$178.52 million in FY2022 and -$115.09 million in FY2021.
- The fiscal Q2 2026 figure represents the lowest quarterly EBITDA in data going back to fiscal Q3 2019.
- Business Quant data shows NRIX's EBITDA at -$90.3 million (Q1 2026), -$80.98 million (Q4 2025) and -$89.36 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | -91.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -91.95 Mn |
| Feb 28, 2026 | -90.30 Mn |
| Nov 30, 2025 | -80.98 Mn |
| Aug 31, 2025 | -89.36 Mn |
| May 31, 2025 | -46.08 Mn |
| Feb 28, 2025 | -60.51 Mn |
| Nov 30, 2024 | -62.11 Mn |
| Aug 31, 2024 | -52.22 Mn |
| May 31, 2024 | -46.21 Mn |
| Feb 29, 2024 | -43.17 Mn |
| Nov 30, 2023 | -43.40 Mn |
| Aug 31, 2023 | -38.06 Mn |
| May 31, 2023 | -24.87 Mn |
| Feb 28, 2023 | -41.20 Mn |
| Nov 30, 2022 | -47.07 Mn |
| Aug 31, 2022 | -45.22 Mn |
| May 31, 2022 | -44.42 Mn |
| Feb 28, 2022 | -41.75 Mn |
| Nov 30, 2021 | -37.19 Mn |
| Aug 31, 2021 | -28.30 Mn |
API Access
Nurix Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();